Cushing`s disease: Fibrinogen and D-dimer levels fail to normalize despite early postoperative remission - a

Przemysław Witek, Grzegorz Zieliński1, Katarzyna Szamotulska

  • 1Department of Neurosurgery, Military Institute of Medicine, ul. Szaserów 128, 04-141 Warsaw, Poland.. gzielinski@wim.mil.pl.

Endokrynologia Polska
|February 18, 2016
PubMed

Insights

Even after successful transsphenoidal surgery (TSS) for Cushing's disease (CD), elevated fibrinogen and D-dimer levels persist, indicating a continued risk for thrombotic events and cardiovascular complications in patients with early remission.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Transsphenoidal surgery (TSS) is effective for Cushing's disease (CD), normalizing cortisol and reducing hypercortisolism complications.
  • However, cardiovascular morbidity remains a concern even after successful CD treatment.

Purpose of the Study:

  • To prospectively investigate the dynamics of fibrinogen and D-dimer levels for six months post-effective TSS in CD patients.
  • To compare these levels with healthy controls.

Main Methods:

  • A prospective, controlled study involving 40 CD patients and 40 healthy controls.
  • Assessment of ACTH, cortisol, fibrinogen, and D-dimer levels before TSS and during a six-month follow-up.

Main Results:

  • CD patients exhibited higher baseline BMI, fibrinogen, and D-dimer levels compared to controls.
  • Elevated fibrinogen was independent of BMI and associated with hsCRP and hypertension.
  • Sustained differences in fibrinogen and D-dimer levels were observed between the CD remission group and controls at six months.

Conclusions:

  • Fibrinogen and D-dimer levels did not decrease despite early biochemical remission of CD.
  • These persistent elevations suggest a high risk for thrombotic events.
  • Close follow-up for thromboembolic and cardiovascular complications is crucial for CD patients in early remission.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
737
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
433
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
602
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K